US Patent Issued to IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY on Nov. 4 for "Anticancer agents comprising a g-C3N4@CuO/MgAl2O4 nanohybrid" (Saudi Arabia Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,458,662, issued on Nov. 4, was assigned to IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY (Riyadh, Saudi Arabia).

"Anticancer agents comprising a g-C3N4@CuO/MgAl2O4 nanohybrid" was invented by Babiker Yagoub Elhadi Abdulkhair (Riyadh, Saudi Arabia) and Mohamed Khairy Abdel Fattah Omran (Riyadh, Saudi Arabia).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of inhibiting cell growth in a cancer includes contacting a graphite-phase carbon nitride copper oxide and magnesium aluminum oxide (g-C3N4@CuO/MgAl2O4) nanocomposite with the cancer to inhibit growth of the cancer. The g-C3N4@CuO/MgAl2O4 nanocomposite comprises a graphite-phase carbon nitride (g-C3N4...